Stock Track | TransMedics Group Soars 5.22% on Upbeat Q4 Results and Positive Outlook

Stock Track2025-03-05

TransMedics Group, Inc. (TMDX) saw its stock surge 5.22% in the intraday session on Tuesday, following the company's impressive fourth-quarter 2024 financial results and optimistic guidance for the current year.

The medical technology company reported strong revenue growth for Q4 2024, with revenue reaching $122 million, representing a significant increase from the previous year. Additionally, TransMedics recorded a notable jump in net income, climbing to nearly $7 million, a remarkable turnaround from the net loss reported in the prior year.

Investors were further buoyed by TransMedics' positive revenue guidance for 2025, with the company anticipating a 20% to 25% increase in revenue. This outlook likely fueled confidence in the company's growth prospects, driving the stock's substantial intraday gain.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1145367826?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-05 09:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1145367826","market":"hk","top_or_hot":-1,"title":"Stock Track | TransMedics Group Soars 5.22% on Upbeat Q4 Results and Positive Outlook","media":"Stock Track","content":"<p>TransMedics Group, Inc. (TMDX) saw its stock surge 5.22% in the intraday session on Tuesday, following the company's impressive fourth-quarter 2024 financial results and optimistic guidance for the current year.</p>\n\n<p>The medical technology company reported strong revenue growth for Q4 2024, with revenue reaching $122 million, representing a significant increase from the previous year. Additionally, TransMedics recorded a notable jump in net income, climbing to nearly $7 million, a remarkable turnaround from the net loss reported in the prior year.</p>\n\n<p>Investors were further buoyed by TransMedics' positive revenue guidance for 2025, with the company anticipating a 20% to 25% increase in revenue. This outlook likely fueled confidence in the company's growth prospects, driving the stock's substantial intraday gain.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | TransMedics Group Soars 5.22% on Upbeat Q4 Results and Positive Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | TransMedics Group Soars 5.22% on Upbeat Q4 Results and Positive Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-03-05 09:16</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>TransMedics Group, Inc. (TMDX) saw its stock surge 5.22% in the intraday session on Tuesday, following the company's impressive fourth-quarter 2024 financial results and optimistic guidance for the current year.</p>\n\n<p>The medical technology company reported strong revenue growth for Q4 2024, with revenue reaching $122 million, representing a significant increase from the previous year. Additionally, TransMedics recorded a notable jump in net income, climbing to nearly $7 million, a remarkable turnaround from the net loss reported in the prior year.</p>\n\n<p>Investors were further buoyed by TransMedics' positive revenue guidance for 2025, with the company anticipating a 20% to 25% increase in revenue. This outlook likely fueled confidence in the company's growth prospects, driving the stock's substantial intraday gain.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TMDX","symbol_name":"Transmedics Group","start_time":0,"source_url":"","article_id":"1145367826","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1145367826","pubTimestamp":1741137398,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"TransMedics Group, Inc.  saw its stock surge 5.22% in the intraday session on Tuesday, following the company's impressive fourth-quarter 2024 financial results and optimistic guidance for the current year.The medical technology company reported strong revenue growth for Q4 2024, with revenue reaching $122 million, representing a significant increase from the previous year. Additionally, TransMedics recorded a notable jump in net income, climbing to nearly $7 million, a remarkable turnaround from","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TMDX":"Transmedics Group"},"translate_title":"TransMedics Group因乐观的第四季度业绩和积极的前景而飙升5.22%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TMDX":1},"content_text":"TransMedics Group, Inc. (TMDX) saw its stock surge 5.22% in the intraday session on Tuesday, following the company's impressive fourth-quarter 2024 financial results and optimistic guidance for the current year.\nThe medical technology company reported strong revenue growth for Q4 2024, with revenue reaching $122 million, representing a significant increase from the previous year. Additionally, TransMedics recorded a notable jump in net income, climbing to nearly $7 million, a remarkable turnaround from the net loss reported in the prior year.\nInvestors were further buoyed by TransMedics' positive revenue guidance for 2025, with the company anticipating a 20% to 25% increase in revenue. This outlook likely fueled confidence in the company's growth prospects, driving the stock's substantial intraday gain.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1145367826","isCrawlerRequest":true}